ALFA Finder| Management target | Revenue 100.0% FY30 |
|---|
| Revenue growth | 20.01% YoY in Q1 FY27. |
|---|---|
| Margins | EBITDA margin 24.6%; expected to sustain north of 20%. |
| Order book | Long-term contracts with Givaudan, P&G, and Henkel. |
| Demand visibility | Broad-based demand across domestic and export markets. |
| Management confidence | High; citing resilience and structural business strength. |
Growth
Revenue grew 20.01% YoY to Rs 681.42 Cr; Net Profit surged 35.97% YoY to Rs 84.21 Cr.
Outlook
Targeting Rs 5,000 Cr revenue and Rs 1,000 Cr+ EBITDA by FY29-30. Expansion projects operational by H2 2028.
Risks
One-off fire loss of Rs 2.78 Cr; adverse global headwinds and potential supply chain vulnerabilities mentioned.
Last quarter's promises, checked
Delivered
- Guided 20% revenue growth → delivered 20.01% (= BEAT)
- Guided 20%+ EBITDA margins → delivered 24.6% (= BEAT)
- Guided PRIGIV JV profitability → delivered Q1 FY27 profits (= BEAT)
Partly delivered
- Guided Phase 1 capex completion by June 30, 2026 → delivered operational ramp-up in Q1 FY27 (= PARTIAL)
Investor Presentation filed with BSE, NSE: PRIVISCL. Summary written with AI assistance from the document.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,380.40
- Market cap
- ₹13,205 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 35.4×Sector 35.5×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 2.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways
Record Q2 revenue ₹773 Cr (+13.9%), EBITDA ₹212 Cr (+16.7%), PAT ₹117 Cr (+24.6%). H1 growth is about 15%, yet management reiterates 20% for FY27, which needs a sharp H2 acceleration.
- Call
- Guides 20% growth
Privi Speciality Chemicals Other Announcement
Privi Speciality Chemicals Ltd filed its quarterly shareholding pattern for the period ending 30 September 2026. Shareholding Pattern statements are routine regulatory disclosures with no transaction or business event.
Privi Speciality Chemicals Investor Presentation: Key Takeaways
Q2 FY27 total income Rs 773.16 Cr (+13.9%), EBITDA Rs 212.49 Cr (27.5% margin, +65bps), PAT Rs 117.03 Cr (+24.6%). H1 FY27 PAT +29.1%. Targets Rs 5,000 Cr revenue by FY29-30.
Privi Speciality Chemicals Dividend
Privi Speciality Chemicals declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its 29 October 2026 board meeting. Record date is 04 November 2026 and payment by 25 November 2026.
Privi Speciality Chemicals Q2 FY27 Results: Net Profit ₹117.5 Cr, Up 30.3% YoY
Privi Speciality Chemicals Ltd reported revenue from operations of ₹760.5 Cr (+12.1% YoY) and net profit of ₹117.5 Cr (+30.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹117.5 Cr · +30.3% YoY
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals' NCLT-convened equity shareholder meeting approved the Scheme of Amalgamation of Privi Fine Sciences and Privi Biotechnologies into the company. The special resolution passed with requisite majority, subject to scrutinizer report.